2026-01-23 - Analysis Report
**Financial Report: Albemarle (ALB)**

**Company Overview:** Albemarle is a global leader in the production of lithium and other specialty chemicals.

**Return Rate Comparison:**

* Ticker: ALB
* Cumulative Return: 68.01%
* S&P 500 (VOO) Cumulative Return: 92.53%
* Divergence (Max: 166.50, Min: -116.60, Current: -47.80, Relative Divergence: 24.30%)

**Alpha, Beta Analysis:**

| Year | CAGR | MDD | Alpha | Beta | Cap (B) |
|------|------|------|-------|------|-------|
| 2016-2018 | -10.0% | 35.3% | -14.0% | 1.2 | 9.1B |
| 2017-2019 | -37.0% | 35.3% | -54.0% | 1.2 | 8.6B |
| 2018-2020 | 50.0% | 29.5% | 29.0% | 1.2 | 17.4B |
| 2019-2021 | 140.0% | 29.5% | 96.0% | 1.3 | 27.5B |
| 2020-2022 | 134.0% | 28.5% | 136.0% | 1.3 | 25.5B |
| 2021-2023 | -26.0% | 53.3% | -27.0% | 1.5 | 17.0B |
| 2022-2024 | -139.0% | 68.7% | -158.0% | 1.5 | 10.1B |
| 2023-2025 | -165.0% | 74.5% | -228.0% | 1.8 | 16.6B |

**Stock Price Fluctuations:**

* Close: $188.32
* Last Market: {'price': 188.32, 'previousClose': 180.06, 'change': 4.59}
* 5-day SMA: $175.55
* 20-day SMA: $160.20
* 60-day SMA: $131.90

**RSI, PPO Index Indicators:**

* Market Risk Indicator (MRI): 0.90 (High Investment Recommended)
* RSI: 78.47
* PPO: 0.59
* Hybrid Signal: Buy (Cash 0%)
* Recent (20 days) relative divergence change: 0.80 (+) improving
* 7-day Rank change: 26 (+) rank up
* 7-day Dynamic Expected Return change: -0.10 (-) worsening
* Expected Return: 2.80%

**Recent News & Significant Events:**

* Is It Worth Investing in Albemarle (ALB) Based on Wall Street's Bullish Views? - Finviz
* Albemarle (ALB) Surpasses Market Returns: Some Facts Worth Knowing - Yahoo Finance
* Albemarle (NYSE:ALB) Stock Rating Upgraded by Hsbc Global Res - MarketBeat
* Here's Why Albemarle Stock Powered Higher Today - The Motley Fool
* 'Influx Of Investor Interest' On Lithium Sends Albemarle To 2-Year Highs - Investor's Business Daily
* Albemarle jumps to new multiyear high after winning its sixth analyst upgrade this month (ALB:NYSE) - Seeking Alpha

**Analyst Opinions:**

Analyst Consensus:
* Key: Buy
* Mean (1=StrongBuy~5=Sell): 2.15 (~Buy)
* Opinions: 23
* Target Price (avg/high/low): 165.06 / 210.00 / 80.00

**Recent Earnings Analysis:**

| Date | EPS | Revenue |
|---|---:|---:|
| 2025-11-05 | -1.72 | 1.31 B$ |
| 2025-08-04 | -0.16 | 1.33 B$ |
| 2025-04-30 | 0 | 1.08 B$ |
| 2024-11-06 | -9.45 | 1.35 B$ |
| 2025-11-05 | -9.45 | 1.35 B$ |

The quarterly data shows a significant decrease in EPS and revenue in 2024-2025 compared to the previous years. However, the revenue has been increasing consistently since 2024 Q2.

**Financial Information:**

**Revenue and Profitability:**

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-09-30 | $1.31B | 8.99% |
| 2025-06-30 | $1.33B | 14.80% |
| 2025-03-31 | $1.08B | 14.51% |
| 2024-12-31 | $1.23B | 11.22% |
| 2024-09-30 | $1.35B | -7.68% |

**Capital and Profitability:**

| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-09-30 | $10.00B | -1.61% |
| 2025-06-30 | $10.24B | 0.22% |
| 2025-03-31 | $10.03B | 0.41% |
| 2024-12-31 | $9.96B | 0.76% |
| 2024-09-30 | $10.24B | -10.44% |

The financial information shows a significant decrease in profit margin and ROE in 2024-2025 compared to the previous years. However, the revenue has been increasing consistently since 2024 Q2.

**Comprehensive Analysis:**

* Return rate comparison: 68.01% vs S&P 500 (92.53%) with a divergence of -47.80 and relative divergence of 24.30%
* Alpha, Beta analysis: inconsistent results with high Beta levels
* Stock price fluctuations: 5-day SMA ($175.55), 20-day SMA ($160.20), 60-day SMA ($131.90)
* RSI, PPO index indicators: RSI (78.47), PPO (0.59), Market Risk Indicator (MRI) 0.90 (High Investment Recommended)
* Recent News & Significant Events: positive news and upgrades from analysts
* Analyst Opinions: BUY recommendation with a target price of $165.06
* Recent Earnings Analysis: significant decrease in EPS and revenue in 2024-2025
* Financial Information: significant decrease in profit margin and ROE in 2024-2025

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.